Cargando…
A year in heart failure: an update of recent findings
Major changes have occurred in these last years in heart failure (HF) management. Landmark trials and the 2021 European Society of Cardiology guidelines for the diagnosis and treatment of HF have established four classes of drugs for treatment of HF with reduced ejection fraction: angiotensin‐conver...
Autores principales: | Stretti, Lorenzo, Zippo, Dauphine, Coats, Andrew J.S., Anker, Markus S., von Haehling, Stephan, Metra, Marco, Tomasoni, Daniela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9073717/ https://www.ncbi.nlm.nih.gov/pubmed/34918477 http://dx.doi.org/10.1002/ehf2.13760 |
Ejemplares similares
-
Heart failure in the last year: progress and perspective
por: Tomasoni, Daniela, et al.
Publicado: (2020) -
COVID-19 and Heart Failure: From Epidemiology During the Pandemic to Myocardial Injury, Myocarditis, and Heart Failure Sequelae
por: Italia, Leonardo, et al.
Publicado: (2021) -
Heart failure: an update from the last years and a look at the near future
por: Riccardi, Mauro, et al.
Publicado: (2022) -
Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: update 2021
por: von Haehling, Stephan, et al.
Publicado: (2021) -
Ethical guidelines for publishing in the journal of cachexia, sarcopenia and muscle: update 2017
por: von Haehling, Stephan, et al.
Publicado: (2017)